AI-generated summary
The authors describe two patients with Bell's palsy, one chronic and one acute, treated with infrared laser photobiomodulation at 808 nm. They report pain reduction, improved facial mobility, and functional recovery in both cases, with follow-up up to three years. The study includes only two cases, so the findings cannot be generalized.
- Participants
- 2
- Who or what was studied
- Two patients with Bell's palsy: a 58-year-old woman with chronic left-sided palsy and a 15-year-old adolescent with acute palsy
- Wavelengths
- 808 nm
- Limits stated in the abstract
- The report covers only two case patients, and the abstract does not describe a control group or formal comparison.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Neuropathy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.